ROTEM
Medical University of South Carolina Professor
http://www.musc.edu
 


The ability to monitor the formation of a blood clot in whole blood can be used to rapidly establish whether there is a defect in plasma coagulation factors, fibrinogen concentration and/or platelet count. The ROTEM assays 



Parameter Definition Information
Clotting Time CT (sec) Time to reach 2mm amplitude from beginning of test Speed of fibrin formation; influenced by clotting factors, anti-coagulants
Clot Formation Time CFT (sec) Time to reach 20mm amplitude from the time of 2mm amplitude Kinetics of clot formation; influenced by platelet level / function and fibrinogen level / ability to polymerize
Maximum Clot Firmness, MCF  Maximum amplitude (in mm)  Firmness of clot, i.e., clot quality; influenced by platelets, fibrinogen (concentration and ability to polymerize), Factor XIII, fibrinolysis
Maximum Lysis, ML (% of MCF) Percent of clot firmess lost during measurement Abnormal ML at 30 minutes likely indicates fibrinolysis












Last updated  2015/07/12 13:28:10 EDTHits  354